http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100314904-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1081 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00 |
| filingDate | 1999-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100314904-B1 |
| titleOfInvention | Peptide with inhibiting activity against ST3Gal I sialyltransferase |
| abstract | The present invention relates to a synthetic peptide having an inhibitory ability against sialic acid transferase (ST3Gal I sialyltransferase), wherein the peptide of the present invention having the amino acid sequence of SEQ ID NO: 5 (WWWWNG-NH 2 structure) is used in animal cells including humans. Inhibition of sialic acid transfer in the formation of the core-I structure of the Ser / Thr-linked glycosylation process may contribute to the formation of the final core-I structure containing no sialic acid. It can be used to prevent and treat breast cancer as an anticancer substance that specifically normalizes abnormal O-glycosylation of human breast cancer cells. |
| priorityDate | 1999-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.